HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linkage analysis in a Dutch family with X-linked recessive congenital stationary night blindness (XL-CSNB).

Abstract
Linkage analysis has been performed in a large Dutch pedigree with X-linked recessive congenital stationary night blindness (CSNB) by utilizing 16 DNA markers from the proximal short arm of the human X chromosome (Xp21.1-11.2). Thirteen polymorphic markers are at least partially informative and have enabled pairwise and multipoint linkage analysis. For three loci, i.e. DXS228, the monoamine oxidase B gene and the Norrie disease gene (NDG), multipoint linkage studies have yielded maximum lod scores of > 3.0 at a recombination fraction of zero. Analysis of recombination events has enabled us to rule out the possibility that the underlying defect in this family is allelic to RP3; the gene defect could also be excluded from the proximal part of the region known to carry RP2. Linkage data are consistent with a possible involvement of the NDG but mutations in the open reading frame of this gene have not been found.
AuthorsW Berger, G van Duijnhoven, A Pinckers, A Smits, H H Ropers, F Cremers
JournalHuman genetics (Hum Genet) Vol. 95 Issue 1 Pg. 67-70 (Jan 1995) ISSN: 0340-6717 [Print] Germany
PMID7814029 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Eye Proteins
  • Genetic Markers
  • NDP protein, human
  • Nerve Tissue Proteins
Topics
  • Chromosome Mapping
  • Eye Proteins (genetics)
  • Female
  • Genes, Recessive
  • Genetic Linkage
  • Genetic Markers
  • Humans
  • Male
  • Nerve Tissue Proteins (genetics)
  • Netherlands
  • Night Blindness (congenital, genetics)
  • Pedigree
  • X Chromosome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: